Kanto Nagai

Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity

Takao Kataoka, N Shinohara, Hajime Takayama et al. · The Journal of Immunology · 1996 · 384 citations · Full text

Life Sciences, Cell Biology, Pharmacology +13

Quenched Light Hadron Spectrum

Sinya Aoki, G. Boyd, R. Burkhalter et al. · Physical Review Letters · 2000 · 194 citations · Full text

Natural Sciences, Physics, Computational Physics +11

Phase structure and critical temperature of two-flavor QCD with a renormalization group improved gauge action and clover improved Wilson quark action

A. Ali Khan, Sinya Aoki, R. Burkhalter et al. · Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D. Particles and fields · 2000 · 159 citations · Full text

Natural Sciences, Physics, Nuclear Physics +16

A new neuromodulatory pathway with a glial contribution mediated via A_2a adenosine receptors

Tomoyuki Nishizaki, Kanto Nagai, Tamotsu Nomura et al. · Glia · 2002 · 131 citations

Life Sciences, Neuroscience, Pharmacology +17

Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H+-ATPase, on CTL-mediated cytotoxicity.

Takao Kataoka, Kenichi Takaku, Junji Magae et al. · The Journal of Immunology · 1994 · 120 citations

Life Sciences, Cell Biology, Pharmacology +14